Q2 2024 Holdings
Filed 2024-08-14 | 112 holdings | $3.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $265.2M | 2,460,417 | 8.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $140.0M | 275,000 | 4.2% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $132.8M | 298,500 | 4.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $129.4M | 940,000 | 3.9% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $110.0M | 121,500 | 3.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $98.6M | 229,250 | 3.0% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $79.5M | 1,177,500 | 2.4% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $79.1M | 1,924,072 | 2.4% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $78.0M | 4,077,500 | 2.3% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $68.8M | 245,499 | 2.1% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $63.0M | 817,500 | 1.9% |
| Freshpet Inc(FRPT) | COM | 358039105 | $62.1M | 480,000 | 1.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $60.8M | 250,000 | 1.8% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $60.6M | 1,772,038 | 1.8% |
| Merus N V | COM | N5749R100 | $59.2M | 1,001,073 | 1.8% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $58.2M | 119,500 | 1.8% |
| Agilon Health Inc(AGL) | COM | 00857U107 | $58.2M | 8,900,000 | 1.8% |
| Dexcom Inc(DXCM) | COM | 252131107 | $56.7M | 500,000 | 1.7% |
| Humana Inc(HUM) | COM | 444859102 | $55.1M | 147,408 | 1.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $54.2M | 808,356 | 1.6% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $52.6M | 1,280,493 | 1.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $51.8M | 1,398,994 | 1.6% |
| Phreesia Inc(PHR) | COM | 71944F106 | $51.3M | 2,417,500 | 1.5% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $50.8M | 550,000 | 1.5% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $49.6M | 1,272,877 | 1.5% |
| West Pharmaceutical Svsc Inc(WST) | COM | 955306105 | $47.9M | 145,500 | 1.4% |
| Penumbra Inc(PEN) | COM | 70975L107 | $47.7M | 265,000 | 1.4% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $45.7M | 1,081,500 | 1.4% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $45.0M | 1,044,261 | 1.4% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $44.9M | 284,000 | 1.4% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $42.8M | 397,500 | 1.3% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $39.6M | 290,000 | 1.2% |
| Insulet Corp(PODD) | COM | 45784P101 | $39.4M | 195,000 | 1.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $39.3M | 999,862 | 1.2% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $36.8M | 4,482,265 | 1.1% |
| Azenta Inc(AZTA) | COM | 114340102 | $36.6M | 696,000 | 1.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $36.6M | 943,195 | 1.1% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $34.7M | 1,163,973 | 1.0% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $33.4M | 9,283,492 | 1.0% |
| Warby Parker Inc(WRBY) | CL A COM | 93403J106 | $33.4M | 2,080,000 | 1.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $31.3M | 1,185,654 | 0.9% |
| Align Technology Inc(ALGN) | COM | 016255101 | $30.8M | 127,500 | 0.9% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $25.2M | 1,074,261 | 0.8% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $24.8M | 170,000 | 0.7% |
| Lifestance Health Group Inc(LFST) | COM | 53228F101 | $23.7M | 4,827,700 | 0.7% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $22.5M | 1,297,873 | 0.7% |
| Pacira Biosciences Inc(PCRX) | COM | 695127100 | $22.5M | 785,000 | 0.7% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $22.4M | 505,786 | 0.7% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $22.4M | 3,619,258 | 0.7% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $21.1M | 147,500 | 0.6% |